128 related articles for article (PubMed ID: 32750154)
1. Th2 cell markers in peripheral blood increase during an acute asthma exacerbation.
Shrestha Palikhe N; Wu Y; Konrad E; Gandhi VD; Rowe BH; Vliagoftis H; Cameron L
Allergy; 2021 Jan; 76(1):281-290. PubMed ID: 32750154
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of circulating CD4(+) CRTh2(+) T cells characterize severe asthma.
Palikhe NS; Laratta C; Nahirney D; Vethanayagam D; Bhutani M; Vliagoftis H; Cameron L
Clin Exp Allergy; 2016 Jun; 46(6):825-36. PubMed ID: 27079298
[TBL] [Abstract][Full Text] [Related]
3. Impact of high-altitude therapy on type-2 immune responses in asthma patients.
Boonpiyathad T; Capova G; Duchna HW; Croxford AL; Farine H; Dreher A; Clozel M; Schreiber J; Kubena P; Lunjani N; Mirer D; Rückert B; Satitsuksanoa P; Tan G; Groenen PMA; Bersuch E; Akdis M; Strasser DS; Renner ED; Akdis CA
Allergy; 2020 Jan; 75(1):84-94. PubMed ID: 31267528
[TBL] [Abstract][Full Text] [Related]
4. ILC2s Induce Adaptive Th2-Type Immunity in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Jiang M; Liu H; Li Z; Wang J; Zhang F; Cao K; Li F; Ding J
Mediators Inflamm; 2019; 2019():3140183. PubMed ID: 31320835
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy.
Corrigan CJ; Hamid Q; North J; Barkans J; Moqbel R; Durham S; Gemou-Engesaeth V; Kay AB
Am J Respir Cell Mol Biol; 1995 May; 12(5):567-78. PubMed ID: 7742019
[TBL] [Abstract][Full Text] [Related]
6. The single nucleotide polymorphism CRTh2 rs533116 is associated with allergic asthma and increased expression of CRTh2.
Campos Alberto E; Maclean E; Davidson C; Palikhe NS; Storie J; Tse C; Brenner D; Mayers I; Vliagoftis H; El-Sohemy A; Cameron L
Allergy; 2012 Nov; 67(11):1357-64. PubMed ID: 22947041
[TBL] [Abstract][Full Text] [Related]
7. Stability of peripheral blood immune markers in patients with asthma.
Shrestha Palikhe N; Bosonea AM; Laratta C; Gandhi VD; Nahirney D; Hillaby A; Bowen M; Bhutani M; Mayers I; Cameron L; Vliagoftis H
Allergy Asthma Clin Immunol; 2019; 15():30. PubMed ID: 31168305
[TBL] [Abstract][Full Text] [Related]
8. Depletion of major pathogenic cells in asthma by targeting CRTh2.
Huang T; Hazen M; Shang Y; Zhou M; Wu X; Yan D; Lin Z; Solon M; Luis E; Ngu H; Shi Y; Katewa A; Choy DF; Ramamoorthi N; Castellanos ER; Balazs M; Xu M; Lee WP; Matsumoto ML; Payandeh J; Arron JR; Hongo JA; Wang J; Hötzel I; Austin CD; Reif K
JCI Insight; 2016 May; 1(7):e86689. PubMed ID: 27699264
[TBL] [Abstract][Full Text] [Related]
9. Elevated Circulating Th2 Cells in Women With Asthma and Psychological Morbidity: A New Asthma Endotype?
Cameron L; Palikhe NS; Laratta C; Vliagoftis H
Clin Ther; 2020 Jun; 42(6):1015-1031. PubMed ID: 32482491
[TBL] [Abstract][Full Text] [Related]
10. Determination of the cutoff values of Th2 markers for the prediction of future exacerbation in severe asthma: An analysis from the Hokkaido Severe Asthma Cohort Study.
Kimura H; Makita H; Taniguchi N; Takei N; Matsumoto M; Kimura H; Goudarzi H; Shimizu K; Suzuki M; Nishimura M; Konno S;
Allergol Int; 2021 Jan; 70(1):68-73. PubMed ID: 32952040
[TBL] [Abstract][Full Text] [Related]
11. Allergen-induced Increases in Sputum Levels of Group 2 Innate Lymphoid Cells in Subjects with Asthma.
Chen R; Smith SG; Salter B; El-Gammal A; Oliveria JP; Obminski C; Watson R; O'Byrne PM; Gauvreau GM; Sehmi R
Am J Respir Crit Care Med; 2017 Sep; 196(6):700-712. PubMed ID: 28422515
[TBL] [Abstract][Full Text] [Related]
12. The CRTh2 polymorphism rs533116 G > A associates with asthma severity in older females.
Shrestha Palikhe N; Mackenzie CA; Licskai C; Kim RB; Vliagoftis H; Cameron L
Front Med (Lausanne); 2022; 9():970495. PubMed ID: 36314028
[TBL] [Abstract][Full Text] [Related]
13. Type 2 innate lymphoid cells: A novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma.
Liu T; Wu J; Zhao J; Wang J; Zhang Y; Liu L; Cao L; Liu Y; Dong L
Respir Med; 2015 Nov; 109(11):1391-6. PubMed ID: 26459159
[TBL] [Abstract][Full Text] [Related]
14. [The evolvement of Th1/Th2 imbalance accommodates to the progress of airway inflammation in asthmatic subjects and rat model].
Shi JH; Li TS; Lin YG
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1440-4. PubMed ID: 15500739
[TBL] [Abstract][Full Text] [Related]
15. Collaborative interactions between type 2 innate lymphoid cells and antigen-specific CD4+ Th2 cells exacerbate murine allergic airway diseases with prominent eosinophilia.
Liu B; Lee JB; Chen CY; Hershey GK; Wang YH
J Immunol; 2015 Apr; 194(8):3583-93. PubMed ID: 25780046
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood intermediate monocyte protease-activated receptor-2 expression increases during asthma exacerbations and after inhalation allergen challenge.
Palikhe NS; Gandhi VD; Wu Y; Sinnatamby T; Rowe BH; Mayers I; Cameron L; Vliagoftis H
Ann Allergy Asthma Immunol; 2021 Aug; 127(2):249-256.e2. PubMed ID: 33895420
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Utility of Noninvasive Type 2 Inflammatory Markers for Prediction of Severe Asthma Exacerbations in Children and Adolescents.
Shah SP; Grunwell J; Shih J; Stephenson S; Fitzpatrick AM
J Allergy Clin Immunol Pract; 2019; 7(8):2624-2633.e2. PubMed ID: 31100552
[TBL] [Abstract][Full Text] [Related]
18. IL-13
Jia Y; Fang X; Zhu X; Bai C; Zhu L; Jin M; Wang X; Hu M; Tang R; Chen Z
Am J Respir Cell Mol Biol; 2016 Nov; 55(5):675-683. PubMed ID: 27314535
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase Cθ controls type 2 innate lymphoid cell and T
Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D
J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240
[TBL] [Abstract][Full Text] [Related]
20. Prospective predictors of exacerbation status in severe asthma over a 3-year follow-up.
Kimura H; Konno S; Makita H; Taniguchi N; Shimizu K; Suzuki M; Kimura H; Goudarzi H; Nakamaru Y; Ono J; Ohta S; Izuhara K; Ito YM; Wenzel SE; Nishimura M;
Clin Exp Allergy; 2018 Sep; 48(9):1137-1146. PubMed ID: 29781543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
